Aesthetic medicine enhances individuals' physical appearance and well-being, addressing both cosmetic concerns and boosting self-confidence. Beyond cosmetic improvements, it often contributes to mental health by positively impacting self-esteem and body image. Aesthetic procedures can also provide non-invasive or minimally invasive solutions for age-related concerns, offering alternatives to surgical interventions. As a rapidly growing field, aesthetic medicine aligns with evolving societal preferences for personalized beauty and contributes significantly to the global healthcare and wellness industry.
According to Data Bridge Market Research analyses the Global Aesthetic Medicine Market is expected to reach the value of USD 26.68 billion by the year 2029, at a CAGR of 9.34% during the forecast period 2022 to 2029.
"Rise in awareness of aesthetic procedures boosts the market growth"
The rising awareness of aesthetic procedures in emerging economies serves as a significant driver for the aesthetic medicine market. Increased exposure to global beauty standards, advancements in media, and growing internet penetration contribute to heightened awareness. As populations in emerging economies become more informed about available aesthetic treatments, the demand for such procedures surges. This trend is further propelled by a cultural shift emphasizing personal appearance, fueling robust market growth for aesthetic medicine in these regions.
What restraints the growth of the global aesthetic medicine market?
“Extended test durations hamper the market growth”
Extended test durations serve as a notable constraint in the aesthetic medicine market, impeding swift product development and market entry. Prolonged testing phases can result in delayed product launches, hindering companies from responding promptly to evolving consumer demands and technological advancements. These extended timelines also elevate development costs, reducing overall market agility.
Segmentation: Global Aesthetic Medicine Market
The global aesthetic medicine market is segmented on the basis of procedure type, product type, application, gender, end-user, and route of administration.
- On the basis of procedure type, the global aesthetic medicine market is segmented into invasive procedures, and non-invasive procedures
- On the basis of product type, the global aesthetic medicine market is segmented into energy-based devices, implants, and anti-wrinkle products
- On the basis of application, the global aesthetic medicine market is segmented into surgical, and non-surgical
- On the basis of gender, the global aesthetic medicine market is segmented into males, and females
- On the basis of end-user, the global aesthetic medicine market is segmented into medical spas and beauty centres, hospitals and clinics, and home use
- On the basis of route of administration, the global aesthetic medicine market is segmented into oral, and topical
Regional Insights: North America dominates the Global Aesthetic Medicine Market
North America dominates the aesthetic medicine market due to a growing population seeking cosmetic procedures, coupled with a high prevalence of aesthetic concerns. The region's dominance is reinforced by the availability of skilled professionals, technological advancements, and economic prosperity fostering a robust demand for aesthetic treatments.
The Asia-Pacific is expected to experience substantial growth during the forecast period from 2022 to 2029 due to the presence of skilled professionals and a rising disposable income among the population, indicating an increasing demand for aesthetic procedures in the region.
To know more about the study visit, https://www.databridgemarketresearch.com/pt/reports/global-aesthetic-medicine-market
Recent Developments in the Global Aesthetic Medicine Market
- In June 2020, Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), achieved FDA approval for JUVÉDERM VOLUMA XC. This approval pertains to the augmentation of the chin region in adults aged 21 and above. Additionally, in 2019, the FDA approved Jeuveau, a product akin to Botox. Notably, Jeuveau offers a cost-effective alternative to Botox
The Prominent Key Players Operating in the Global Aesthetic Medicine Market Include:
- Cynosure, Inc. (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Galderma Laboratories, L.P. (Switzerland)
- Alma Lasers (Israel)
- Allergan (Now part of AbbVie) (Ireland)
- Solta Medical (U.S.)
- Lumenis (Israel)
- Candela Corporation (U.S.)
- Dentsply Sirona (U.S.)
- Merz Pharma (Germany)
- Bausch Health Companies Inc. (Canada)
- Skin Tech Pharma Group (Spain)
- Bioxis Pharmaceuticals (France)
- Obagi Cosmeceuticals LLC (U.S.)
- ZO Skin Health (U.S.)
- Teoxane (Switzerland)
- La RochePosay (Part of L'Oréal) (France)
- Alumier Labs (Canada)
- Medik8 (U.K.)
- Abbott (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global aesthetic medicine market companies contact, https://www.databridgemarketresearch.com/pt/contact
Research Methodology: Global Aesthetic Medicine Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
